Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 May 2013 02:00 PM
RNS
Director/PDMR Shareholding
01 May 2013 07:03 AM
RNS
Collaboration with Novartis
17 Apr 2013 01:00 PM
RNS
2012 ANNUAL REPORT & ACCOUNTS & AGM NOTIFICATION
07 Mar 2013 07:00 AM
RNS
Initiation of PII Collaborative Study for TroVax
27 Feb 2013 07:00 AM
RNS
Preliminary Results
25 Jan 2013 04:40 PM
RNS
Second Price Monitoring Extn
25 Jan 2013 04:35 PM
RNS
Price Monitoring Extension
23 Jan 2013 07:00 AM
RNS
Notice of Preliminary Results
29 Nov 2012 07:00 AM
RNS
Exercise of Option by ImaginAb
28 Nov 2012 07:00 AM
RNS
Block Listing Return
20 Nov 2012 07:00 AM
RNS
Ocular Clinical Programme Update
14 Nov 2012 07:00 AM
RNS
Interim Management Statement
09 Nov 2012 07:00 AM
RNS
Issue of Key US Patent
10 Oct 2012 07:00 AM
RNS
Update on TroVax (R) Development Strategy
03 Oct 2012 07:00 AM
RNS
Board Change
27 Sep 2012 08:00 AM
RNS
Collaboration With Immune Design Corp.
26 Sep 2012 04:40 PM
RNS
Second Price Monitoring Extn
26 Sep 2012 04:35 PM
RNS
Price Monitoring Extension
14 Sep 2012 04:40 PM
RNS
Second Price Monitoring Extn
14 Sep 2012 04:35 PM
RNS
Price Monitoring Extension
10 Sep 2012 12:20 PM
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
31 Aug 2012 07:00 AM
RNS
Interim Results
29 Aug 2012 02:00 PM
RNS
Oxford BioMedica to Present at Conference
10 Aug 2012 11:06 AM
RNS
Block Listing Return
08 Aug 2012 08:00 AM
RNS
Positive DSMB Review of Ongoing Clinical Studies
30 Jul 2012 11:59 AM
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
27 Jul 2012 09:44 AM
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
26 Jul 2012 05:26 PM
RNS
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
25 Jul 2012 11:47 AM
RNS
Result of EGM
25 Jul 2012 07:00 AM
RNS
Notice of Interim Results
25 Jul 2012 07:00 AM
RNS
Results of Firm Placing and Open Offer
23 Jul 2012 07:00 AM
RNS
Funding Award for UshStat(R) Phase I/IIa study
19 Jul 2012 04:40 PM
RNS
Second Price Monitoring Extn
19 Jul 2012 04:35 PM
RNS
Price Monitoring Extension
10 Jul 2012 07:00 AM
RNS
Initiation of Phase II Collaborative Study
06 Jul 2012 01:02 PM
RNS
Notice of posting of prospectus
02 Jul 2012 07:00 AM
RNS
Directors' Interest in Shares and Share Options
29 Jun 2012 07:00 AM
RNS
Proposed Firm Placing and Open Offer
29 Jun 2012 07:00 AM
RNS
US$3 million Option Exercise Payment from Sanofi
21 Jun 2012 11:31 AM
RNS
Holding(s) in Company
08 Jun 2012 07:00 AM
RNS
MHRA Approval for Manufacturing Facility
07 Jun 2012 03:00 PM
RNS
Result of AGM
11 May 2012 07:00 AM
RNS
Interim Management Statement
08 May 2012 07:00 AM
RNS
Presentation of Ocular Clinical Data at ARVO
27 Apr 2012 12:30 PM
RNS
2011 Annual Report and Accounts & AGM Notification
17 Apr 2012 02:00 PM
RNS
Annual Information Update
16 Apr 2012 07:00 AM
RNS
Successful Completion of Phase I/II Study
22 Mar 2012 09:57 AM
RNS
TR-1 Notification of Major Interest in Shares
12 Mar 2012 07:00 AM
RNS
SIGNIFICANT SHAREHOLDING
08 Mar 2012 07:00 AM
RNS
Director / PDMR dealings

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings